You'd think so, but oddly enough these med stocks tend to rise in anticipation of a scheduled FDA meeting, regardless of the outcome. That's how I rode it from $1.50 to $1.70 this spring. We didn't really get any news in the run up to the meeting. My gut started to tell me they werent going to be approved so I dumped at $1.70, luckily.
Market Data 
Markets 
AI
